Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Daily News

Sapien 3 Approved for Use in Intermediate-Risk Patients in Europe

Michael O'Riordan

September 20, 2016

News Daily News

Medtronic Warns of Vascular Trauma, Some Resulting in Death, With CoreValve’s EnVeo R Delivery Catheter

Michael O'Riordan

August 18, 2016

News Daily News

FDA Approves Sapien XT and Sapien 3 for Intermediate-Risk Patients

Yael L. Maxwell

August 18, 2016

News Daily News

Next-Generation CoreValve Device Receives CE Mark for Use in Intermediate-Risk Patients

Todd Neale

August 01, 2016

News Conference News TVT 2016

Minimalist Transfemoral TAVR Reduces Costs Without Adversely Affecting Clinical Outcomes

Michael O'Riordan

June 16, 2016

News Conference News TCT 2015

Boston Scientific Co-founder John Abele Recognized by TCT Career Achievement Award

October 12, 2015

News Daily News

Meta-analysis Confirms Safety of PCI without Surgical Backup

July 16, 2015

News Daily News

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

July 07, 2015

News Daily News

Even With More Experience, Transapical TAVR Offers No Better QoL Than Surgery

Caitlin E. Cox

June 15, 2015

Presentation TCT 2014

Robotics and Remote Device Manipulation: Future Trends and Applications

Presenter: Giora Weisz

September 15, 2014

Presentation TCT 2014

A Dynamic Coning System to Reduce Radiation Dose to Operator, Staff, and Patient During Fluoroscopy and Cine

Presenter: Lindsay S. Machan

September 15, 2014

Presentation TCT 2014

Cath Lab Evolution: Imaging Integration, Radiation Reduction, and Beyond

Presenter: Charles E. Chambers

September 15, 2014

Presentation TCT 2014

Clinician Perspective

Presenter: James A. Goldstein

September 15, 2014

Presentation TCT 2014

Physicist Perspective

Presenter: Stephen Balter

September 15, 2014

Presentation TCT 2013

The Evolution of Interventional Translational Science: The Backbone of ALL Current and Future Catheter-Based Therapies

Presenter: Juan Granada

October 31, 2013

Advertisement

Sapien 3 Approved for Use in Intermediate-Risk Patients in Europe

Medtronic Warns of Vascular Trauma, Some Resulting in Death, With CoreValve’s EnVeo R Delivery Catheter

FDA Approves Sapien XT and Sapien 3 for Intermediate-Risk Patients

Next-Generation CoreValve Device Receives CE Mark for Use in Intermediate-Risk Patients

Minimalist Transfemoral TAVR Reduces Costs Without Adversely Affecting Clinical Outcomes

Boston Scientific Co-founder John Abele Recognized by TCT Career Achievement Award

Meta-analysis Confirms Safety of PCI without Surgical Backup

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

Even With More Experience, Transapical TAVR Offers No Better QoL Than Surgery

Robotics and Remote Device Manipulation: Future Trends and Applications

A Dynamic Coning System to Reduce Radiation Dose to Operator, Staff, and Patient During Fluoroscopy and Cine

Cath Lab Evolution: Imaging Integration, Radiation Reduction, and Beyond

Clinician Perspective

Physicist Perspective

The Evolution of Interventional Translational Science: The Backbone of ALL Current and Future Catheter-Based Therapies

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content